{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:06:44Z","timestamp":1784326004406,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008564","name":"Norwegian Association of the Blind","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtos.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:42:31Z","timestamp":1710348151000},"page":"222-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Tear cytokine levels are reduced in patients treated with intravitreal injections"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-0461","authenticated-orcid":false,"given":"Agni","family":"Malmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilde M.","family":"Thomseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per T.","family":"F\u00f8rland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans C.D.","family":"Aass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjur","family":"Reppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus V.T.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Lindtj\u00f8rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga B.K.","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vegard A.","family":"Forsaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2024.03.004_bib1","article-title":"Intravitreal injections: past trends and future projections within a UK tertiary hospital","author":"Chopra","year":"2021","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.jtos.2024.03.004_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ophtha.2017.01.001","article-title":"Trends in Vitreoretinal procedures for Medicare beneficiaries, 2000 to 2014","volume":"124","author":"McLaughlin","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2024.03.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.01.009","article-title":"Associations between serial intravitreal injections and dry eye","author":"Malmin","year":"2023","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2024.03.004_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2024.03.004_bib5","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enriquez-de-Salamanca","year":"2010","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.jtos.2024.03.004_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2024.03.004_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00417-006-0285-7","article-title":"Th1- and Th2-type cytokines in chronic ocular allergy","volume":"244","author":"Leonardi","year":"2006","journal-title":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"issue":"11","key":"10.1016\/j.jtos.2024.03.004_bib8","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1167\/iovs.16-19757","article-title":"Tear interferon-gamma as a biomarker for evaporative dry eye disease","volume":"57","author":"Jackson","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.03.004_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"23","key":"10.1016\/j.jtos.2024.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.03.004_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/aos.13436","article-title":"Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting","volume":"96","author":"Baudouin","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.03.004_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093111","article-title":"Dry eye disease and tear cytokine levels-A meta-analysis","volume":"21","author":"Roda","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jtos.2024.03.004_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.ico.0000208815.02120.90","article-title":"Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin","volume":"25","author":"Djalilian","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2024.03.004_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology."},{"issue":"4","key":"10.1016\/j.jtos.2024.03.004_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology."},{"issue":"12","key":"10.1016\/j.jtos.2024.03.004_bib16","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1167\/iovs.15-17627","article-title":"Aqueous tear deficiency increases conjunctival interferon-gamma (IFN-gamma) expression and goblet cell loss","volume":"56","author":"Pflugfelder","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.03.004_bib17","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.12659\/MSM.912010","article-title":"Tear luminex analysis in dry eye patients","volume":"24","author":"Zhao","year":"2018","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.jtos.2024.03.004_bib18","first-page":"1429","article-title":"Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia","volume":"43","author":"Zoukhri","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2024.03.004_bib19","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","volume":"87","author":"Barleon","year":"1996","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtos.2024.03.004_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI17712","article-title":"Proinflammatory functions of vascular endothelial growth factor in alloimmunity","volume":"112","author":"Reinders","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtos.2024.03.004_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijsu.2017.06.073","article-title":"Povidone iodine in wound healing: a review of current concepts and practices","volume":"44","author":"Bigliardi","year":"2017","journal-title":"Int J Surg"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2024.03.004_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000246029","article-title":"Effects of Betaisodona on parameters of host defense","volume":"195","author":"Konig","year":"1997","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jtos.2024.03.004_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.burns.2007.11.014","article-title":"Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel\u00ae) for wound healing in vitro","volume":"34","author":"Beukelman","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.jtos.2024.03.004_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.03.004_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jri.2005.03.005","article-title":"Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants","volume":"66","author":"dupont","year":"2005","journal-title":"J Reprod Immunol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T10:29:23Z","timestamp":1714300163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":25,"alternative-id":["S1542012424000338"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.03.004","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tear cytokine levels are reduced in patients treated with intravitreal injections","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}